MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.340
-0.040 (-1.18%)
At close: Mar 10, 2026, 4:00 PM EDT
3.450
+0.110 (3.29%)
After-hours: Mar 10, 2026, 7:58 PM EDT
MDxHealth Stock Forecast
Stock Price Forecast
The 3 analysts that cover MDxHealth stock have a consensus rating of "Strong Buy" and an average price target of $7.67, which forecasts a 129.64% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $9.00.
Price Target: $7.67 (+129.64%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2025.
Analyst Ratings
The average analyst rating for MDxHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +109.58% | Dec 23, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +109.58% | Nov 13, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +169.46% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +109.58% | Nov 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +79.64% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
140.57M
from 107.88M
Increased by 30.31%
Revenue Next Year
166.40M
from 140.57M
Increased by 18.38%
EPS This Year
-0.40
from -0.67
EPS Next Year
-0.11
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 147.0M | 173.7M | ||
| Avg | 140.6M | 166.4M | ||
| Low | 132.3M | 157.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 36.3% | 23.5% | ||
| Avg | 30.3% | 18.4% | ||
| Low | 22.6% | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.21 | 0.05 | |
| Avg | -0.40 | -0.11 | |
| Low | -0.57 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.